Screening may help boost liver cancer survival rates - WICU12 HD WSEE Erie, PA News, Sports, Weather and Events

Screening may help boost liver cancer survival rates

© iStockphoto.com / Thinkstock © iStockphoto.com / Thinkstock
  • Chris Lifestyle Category TESTMore>>

  • COPY-Chris Test 2

    Chris Test 2

    Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1More >>
  • Chris Test 1

    Chris Test 1

    Monday, February 6 2012 4:05 PM EST2012-02-06 21:05:06 GMT
    Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1More >>

WEDNESDAY, May 7, 2014 (HealthDay News) -- Increased screening for liver tumors in people with cirrhosis -- scarring of the liver -- could help boost liver cancer survival rates, according to researchers.

A review of 47 studies that included more than 15,000 patients found the survival rate for those screened with ultrasound scans and blood tests was 51 percent, compared with a 28 percent rate for those who were not screened.

The research team, from the University of Texas Southwestern Medical Center, also found that cirrhosis patients who were screened were more likely to receive treatment for their cancer rather than end-of-life care.

"Curative therapies, such as surgery or a liver transplant, are only available if patients are found to have liver cancer at an early stage. Unfortunately, right now, only a minority of patients' cancers are found at an early stage," study author Dr. Amit Singal, medical director of the liver tumor clinic at UT Southwestern's Harold C. Simmons Cancer Center, said in a medical center news release.

Many cases of liver cancer can be caught early with screening, Singal noted.

"We have a simple test, an abdominal ultrasound, which is painless and easy, but we found that less than 20 percent of at-risk people have the test done, largely due to providers failing to order it," Singal said.

He hopes the findings, published recently in the online journal PLoS Medicine, will help persuade more cirrhosis patients and their doctors that screening is a good idea.

Liver cancer screening is not currently recommended by the U.S. Preventative Services Task Force, partly because no clinical trial has been conducted to assess its effectiveness, Singal noted.

Liver cancer is the third leading cause of cancer death worldwide. People with cirrhosis are at increased risk, and 3 to 5 percent of them develop liver cancer every year.

More information

The U.S. National Library of Medicine has more about cirrhosis.

Copyright © 2014 HealthDay. All rights reserved.

*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
Powered by WorldNow
3514 State St. Erie, PA 16508
Newsroom: (814)454-8812
Toll Free: 1(800)454-8812
Business offices: (814)454-5201
WICU FCC Filing
WSEE FCC Filing
Share:
Share Stories
Submit your stories to our site!
Share Photos
Share your photos in our community galleries
Mobile:
Mobile Site
Be sure to stay constantly updated with the power of WICU12 and WSEE at your fingertips
Free Android App
Free iPhone App
Free iPad App
Storm Tracker App
Droid
iPhone
iPad
All content © Copyright 2000 - 2014 WorldNow and WICU. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.
                   WICU/WSEE - 3514 State Street Erie, PA 16508 - (814) 454-5201 - info@wicu12.com